We propose that the SSO‐QPOP‐derived combination of CHK1 and BRD4 is a pair of MYC synthetic lethal targets with the greatest therapeutic potential in the treatment of MYC‐driven HCC. This evidence concerns the gene BRD4 and hepatocellular carcinoma.